|

mFOLFIRINOX Treatment Regimen Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Also known as: Camptosar, Eloxatin, Fluorouracil, Folinic acid

Pipeline

Phase 1: 1Phase 2: 2

Top Sponsors

  • Shenzhen Xinhe Biomedical1
  • Medical College of Wisconsin1
  • Hopital Foch1

Indications

  • Cancer3
  • Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)1
  • Liver Disease1
  • Pancreas Neoplasms1
  • Pancreatic Ductal Adenocarcinoma (PDAC)1

Other2 trials

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Phase 2
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
Phase 1

Scottsdale, Arizona1 trial

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

HonorHealth Medical Group

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.